NICOLE GRAVES: Open Payments
NPI 1386135374 · ELKHART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$886 in 43 payments from 23 companies in 2025. Trend: 2023 $82 · 2024 $1,137 · 2025 $886
Food & beverage: $866Education: $20
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 6 | $125 |
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| PFIZER INC. | 4 | $64 |
| E.R. Squibb & Sons, L.L.C. | 2 | $51 |
| PharmaEssentia USA Corporation | 2 | $43 |
| JAZZ PHARMACEUTICALS INC. | 2 | $42 |
| Janssen Biotech, Inc. | 2 | $36 |
| Ethicon Inc. | 1 | $35 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $35 |
Products named: KEYTRUDA, OPDIVO, Fabhalta, BESREMI, ZEPZELCA, PLUVICTO, Monarch Platform, NURTEC ODT.
Industry payments across IN — which companies pay providers there.
